A carregar...

Expression of CCL20 and Granulocyte-Macrophage Colony-Stimulating Factor, but Not Flt3-L, from Modified Vaccinia Virus Ankara Enhances Antiviral Cellular and Humoral Immune Responses

While modified vaccinia virus Ankara (MVA) is currently in clinical development as a safe vaccine against smallpox and heterologous infectious diseases, its immunogenicity is likely limited due to the inability of the virus to replicate productively in mammalian hosts. In light of recent data demons...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Chavan, R., Marfatia, K. A., An, I. C., Garber, D. A., Feinberg, M. B.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2006
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1563727/
https://ncbi.nlm.nih.gov/pubmed/16840346
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.02748-05
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!